Venetoclax plus daratumumab induce hematological CR and organ response in an AL amyloidosis patient with t(11;14)
Guido Ghilardi(Hospital of the University of Pennsylvania), B. Gerber(University of Zurich), Luca Mazzucchelli(Istituto Cantonale di Patologia), Georg Stüssi(Institute of Oncology Research), Davide Rossi(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Christoph Röcken(University Hospital Schleswig-Holstein)
Cited by 19
Related Papers
The coding genome of splenic marginal zone lymphoma: activation of <i>NOTCH2</i> and other pathways regulating marginal zone development
|The Journal of Experimental Medicine|2012|378
Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy
|Nature Medicine|2022|308
BCA-1 is highly expressed in Helicobacter pylori–induced mucosa-associated lymphoid tissue and gastric lymphoma
|Journal of Clinical Investigation|1999|300
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy
|Nature Medicine|2024|254